新诺威巨石生物SYS-6002(CRB-701)更新的第1阶段临床数据将在2024年ASCO年会上提交
图片内容软件简单翻译如下:
2024年5月23日(GLOBE NEWSWIRE)-Corbus Pharmaceuticals Holdings, Inc.(纳斯达克:CRBP)(“Corbus”或“...查看全文
半醉半浮生06-04 02:13
$Corbus(CRBP)$ :
这两周太牛!盘前出了GME,继续抄入$CleanSpark(CLSK)$ 、CRBP、CSLR
CRBP管线数据良好,埋伏了几个月,等待收获!查看全文
Corbus(CRBP)05-21 05:05
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-005672 Size: 5 KB 网页链接查看全文
Corbus(CRBP)06-01 04:45
$Corbus(CRBP)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-067373 Act: 33 Size: 443 KB 网页链接查看全文
Corbus(CRBP)06-15 05:35
$Corbus(CRBP)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000152 Act: 33 Size: 5 KB 网页链接查看全文
Corbus(CRBP)06-04 04:35
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-068035 Size: 14 KB 网页链接查看全文
Corbus(CRBP)06-04 04:35
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-068013 Size: 14 KB 网页链接查看全文
Corbus(CRBP)04-11 21:25
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-005284 Size: 7 KB 网页链接查看全文
Corbus(CRBP)06-19 17:25
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075071 Size: 42 KB 网页链接查看全文
美股律师郝俊波2019-03-13 09:37
$Corbus制药控股(CRBP)$ Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP)因证券欺诈案已近于近日被投资者诉至法院。如果您投资该证券受损请点击我们的雪球网相关集体诉讼专题页:网页链接查看全文
美股律师郝俊波2019-03-01 13:25
$Corbus制药控股(CRBP)$ Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP)因被指控犯有证券欺诈者有牵连而且研发的新药lenabasum试验失败等重大不利消息而股价下跌。如果您投资该证券受损,请点击我们的雪球网相关集体诉讼专题页:网页链接查看全文
usbiostock2018-06-29 10:08
回复@滑板鞋2018: 除了GLPG和VRTX,做囊性纤维化(CF)的还有$ProQR Therapeutics N.V. - Ordinary Shares(PRQR)$ $Proteostasis Therapeutics, Inc.(PTI)$ $Corbus Pharmaceuticals Holdings, Inc. (CRBP)$ 还有一家没上市的Celtaxsys也做到临床2b期了,今年夏天会公布数据。这个病不好做,之前已...查看全文
木月皿2015-09-19 10:55
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 10月8-10日 North American Cystic Fibrosis Conference,Resunab抗炎数据(Poster已出),临床前。近期多笔内部买入。查看全文
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075071 Size: 42 KB 网页链接
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-075075 Size: 26 KB 网页链接
$Corbus(CRBP)$ 8-K Current report, item 8.01 Accession Number: 0000950170-24-074032 Act: 34 Size: 148 KB 网页链接
$Corbus(CRBP)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000151 Act: 33 Size: 6 KB 网页链接
$Corbus(CRBP)$ 144 Report of proposed sale of securities Accession Number: 0001972481-24-000152 Act: 33 Size: 5 KB 网页链接
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-073710 Size: 16 KB 网页链接
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-068005 Size: 14 KB 网页链接
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-068009 Size: 14 KB 网页链接
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-068013 Size: 14 KB 网页链接
$Corbus(CRBP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-068014 Size: 14 KB 网页链接